{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:17:28Z","timestamp":1790104648131,"version":"4.0.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Fund Program for Hunan Provincial Natural Science Foundation of China","award":["2023JJ60275"],"award-info":[{"award-number":["2023JJ60275"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s11064-025-04475-y","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T14:39:22Z","timestamp":1752763162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Novel GLP-1\/GIP Dual Receptor Agonist Alleviates Neonatal Hypoxic-Ischemic Encephalopathy by Inhibiting TLR2\/NF-\u03baB\/NLRP3 Mediated-Neuroinflammation"],"prefix":"10.1007","volume":"50","author":[{"given":"Weiqing","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xionghui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"issue":"3","key":"4475_CR1","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00431-021-04320-8","volume":"181","author":"S Victor","year":"2022","unstructured":"Victor S, Rocha-Ferreira E, Rahim A, Hagberg H, Edwards D (2022) New possibilities for neuroprotection in neonatal hypoxic-ischemic encephalopathy. Eur J Pediatr 181(3):875\u2013887","journal-title":"Eur J Pediatr"},{"issue":"1","key":"4475_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/AOG.0000000000005392","volume":"143","author":"T Arnautovic","year":"2024","unstructured":"Arnautovic T, Sinha S, Laptook AR (2024) Neonatal Hypoxic-Ischemic encephalopathy and hypothermia treatment. Obstet Gynecol 143(1):67\u201381","journal-title":"Obstet Gynecol"},{"issue":"5","key":"4475_CR3","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/dmcn.16184","volume":"67","author":"NH Chan","year":"2025","unstructured":"Chan NH, Hawkins CC, Rodrigues BV, Cornet MC, Gonzalez FF, Wu YW (2025) Neuroprotection for neonatal hypoxic-ischemic encephalopathy: A review of novel therapies evaluated in clinical studies. Dev Med Child Neurol 67(5):591\u2013599","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"4475_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s13760-020-01308-3","volume":"120","author":"P Greco","year":"2020","unstructured":"Greco P, Nencini G, Piva I, Scioscia M, Volta CA, Spadaro S, Neri M, Bonaccorsi G, Greco F, Cocco I, Sorrentino F, D\u2019Antonio F, Nappi L (2020) Pathophysiology of hypoxic-ischemic encephalopathy: a review of the past and a view on the future. Acta Neurol Belg 120(2):277\u2013288","journal-title":"Acta Neurol Belg"},{"issue":"1","key":"4475_CR5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12887-021-02737-6","volume":"21","author":"Z Wang","year":"2021","unstructured":"Wang Z, Zhang P, Zhou W, Xia S, Zhou W, Zhou X, Cheng X, Shi Y, Lin Z, Song D, Cheng G (2021) Neonatal hypoxic-ischemic encephalopathy diagnosis and treatment: a National survey in China. BMC Pediatr 21(1):261","journal-title":"BMC Pediatr"},{"issue":"9","key":"4475_CR6","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/s41423-019-0257-6","volume":"17","author":"B Li","year":"2020","unstructured":"Li B, Dasgupta C, Huang L, Meng X, Zhang L (2020) MiRNA-210 induces microglial activation and regulates microglia-mediated neuroinflammation in neonatal hypoxic-ischemic encephalopathy. Cell Mol Immunol 17(9):976\u2013991","journal-title":"Cell Mol Immunol"},{"key":"4475_CR7","doi-asserted-by":"publisher","first-page":"6801587","DOI":"10.1155\/2020\/6801587","volume":"2020","author":"X Hu","year":"2020","unstructured":"Hu X, Li S, Doycheva DM, Huang L, Lenahan C, Liu R, Huang J, Gao L, Tang J, Zuo G, Zhang JH (2020) Rh-CSF1 attenuates oxidative stress and neuronal apoptosis via the CSF1R\/PLCG2\/PKA\/UCP2 signaling pathway in a rat model of neonatal HIE. Oxid Med Cell Longev 2020:6801587","journal-title":"Oxid Med Cell Longev"},{"key":"4475_CR8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pneurobio.2017.10.006","volume":"159","author":"B Li","year":"2017","unstructured":"Li B, Concepcion K, Meng X, Zhang L (2017) Brain-immune interactions in perinatal hypoxic-ischemic brain injury. Prog Neurobiol 159:50\u201368","journal-title":"Prog Neurobiol"},{"key":"4475_CR9","doi-asserted-by":"publisher","first-page":"111030","DOI":"10.1016\/j.intimp.2023.111030","volume":"124","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Zhu T, Chen B, Fang Y, Wu Y, Feng X, Pang M, Wang H, Zhu J, Lin Z (2023) Diallyl disulfide attenuates pyroptosis via NLRP3\/Caspase-1\/IL-1beta signaling pathway to exert a protective effect on hypoxic-ischemic brain damage in neonatal rats. Int Immunopharmacol 124:111030 (Pt B)","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"4475_CR10","doi-asserted-by":"publisher","first-page":"e13674","DOI":"10.1111\/apha.13674","volume":"233","author":"A Rayasam","year":"2021","unstructured":"Rayasam A, Fukuzaki Y, Vexler ZS (2021) Microglia-leucocyte axis in cerebral ischaemia and inflammation in the developing brain. Acta Physiol (Oxf) 233(1):e13674","journal-title":"Acta Physiol (Oxf)"},{"key":"4475_CR11","doi-asserted-by":"publisher","first-page":"1148209","DOI":"10.3389\/fimmu.2023.1148209","volume":"14","author":"SF Mehdi","year":"2023","unstructured":"Mehdi SF, Pusapati S, Anwar MS, Lohana D, Kumar P, Nandula SA, Nawaz FK, Tracey K, Yang H, LeRoith D, Brownstein MJ, Roth J (2023) Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent. Front Immunol 14:1148209","journal-title":"Front Immunol"},{"key":"4475_CR12","doi-asserted-by":"publisher","first-page":"106550","DOI":"10.1016\/j.phrs.2022.106550","volume":"186","author":"KO Kopp","year":"2022","unstructured":"Kopp KO, Glotfelty EJ, Li Y, Greig NH (2022) Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: implications for neurodegenerative disease treatment. Pharmacol Res 186:106550","journal-title":"Pharmacol Res"},{"key":"4475_CR13","doi-asserted-by":"publisher","first-page":"170184","DOI":"10.1016\/j.peptides.2019.170184","volume":"125","author":"ZQ Zhang","year":"2020","unstructured":"Zhang ZQ, Holscher C (2020) GIP has neuroprotective effects in alzheimer and parkinson\u2019s disease models. Peptides 125:170184","journal-title":"Peptides"},{"key":"4475_CR14","doi-asserted-by":"crossref","unstructured":"Rhea EM, Babin A, Thomas P, Omer M, Weaver R, Hansen K, Banks WA, Talbot K (2023) Brain uptake pharmacokinetics of albiglutide, dulaglutide, tirzepatide, and DA5-CH in the search for new treatments of Alzheimer\u2019s and Parkinson\u2019s diseases. Tissue Barriers 2292461","DOI":"10.1080\/21688370.2023.2292461"},{"issue":"8","key":"4475_CR15","doi-asserted-by":"publisher","first-page":"e2231","DOI":"10.1002\/brb3.2231","volume":"11","author":"M Lv","year":"2021","unstructured":"Lv M, Xue G, Cheng H, Meng P, Lian X, Holscher C, Li D (2021) The GLP-1\/GIP dual-receptor agonist DA5-CH inhibits the NF-kappaB inflammatory pathway in the MPTP mouse model of parkinson\u2019s disease more effectively than the GLP-1 single-receptor agonist NLY01. Brain Behav 11(8):e2231","journal-title":"Brain Behav"},{"issue":"2","key":"4475_CR16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/ana.410090206","volume":"9","author":"JE Rice 3rd","year":"1981","unstructured":"Rice JE 3rd, Vannucci RC, Brierley JB (1981) The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 9(2):131\u2013141","journal-title":"Ann Neurol"},{"issue":"8","key":"4475_CR17","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.4103\/1673-5374.389361","volume":"16","author":"LY Zhang","year":"2021","unstructured":"Zhang LY, Jin QQ, Holscher C, Li L (2021) Glucagon-like peptide-1\/glucose-dependent insulinotropic polypeptide dual receptor agonist DA-CH5 is superior to exendin-4 in protecting neurons in the 6-hydroxydopamine rat Parkinson model. Neural Regen Res 16(8):1660\u20131670","journal-title":"Neural Regen Res"},{"issue":"1","key":"4475_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12974-018-1137-1","volume":"15","author":"Z Wang","year":"2018","unstructured":"Wang Z, Meng S, Cao L, Chen Y, Zuo Z, Peng S (2018) Critical role of NLRP3-caspase-1 pathway in age-dependent isoflurane-induced microglial inflammatory response and cognitive impairment. J Neuroinflammation 15(1):109","journal-title":"J Neuroinflammation"},{"issue":"4","key":"4475_CR19","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s11064-013-0968-5","volume":"38","author":"LP Zhao","year":"2013","unstructured":"Zhao LP, Ji C, Lu PH, Li C, Xu B, Gao H (2013) Oxygen glucose deprivation (OGD)\/re-oxygenation-induced in vitro neuronal cell death involves mitochondrial cyclophilin-D\/P53 signaling axis. Neurochem Res 38(4):705\u2013713","journal-title":"Neurochem Res"},{"issue":"2","key":"4475_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.lfs.2014.06.023","volume":"110","author":"MA Ahmed","year":"2014","unstructured":"Ahmed MA, El Morsy EM, Ahmed AA (2014) Pomegranate extract protects against cerebral ischemia\/reperfusion injury and preserves brain DNA integrity in rats. Life Sci 110(2):61\u201369","journal-title":"Life Sci"},{"issue":"1","key":"4475_CR21","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12974-020-1731-x","volume":"17","author":"H Yang","year":"2020","unstructured":"Yang H, Wu L, Deng H, Chen Y, Zhou H, Liu M, Wang S, Zheng L, Zhu L, Lv X (2020) Anti-inflammatory protein TSG-6 secreted by bone marrow mesenchymal stem cells attenuates neuropathic pain by inhibiting the TLR2\/MyD88\/NF-kappaB signaling pathway in spinal microglia. J Neuroinflammation 17(1):154","journal-title":"J Neuroinflammation"},{"key":"4475_CR22","doi-asserted-by":"publisher","first-page":"155230","DOI":"10.1016\/j.phymed.2023.155230","volume":"123","author":"XP Yang","year":"2024","unstructured":"Yang XP, Huang JH, Ye FL, Yv QY, Chen S, Li WW, Zhu M (2024) Echinacoside exerts neuroprotection via suppressing microglial alpha-synuclein\/TLR2\/NF-kappaB\/NLRP3 axis in parkinsonian models. Phytomedicine 123:155230","journal-title":"Phytomedicine"},{"issue":"5","key":"4475_CR23","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1080\/14737175.2017.1259567","volume":"17","author":"EP Yildiz","year":"2017","unstructured":"Yildiz EP, Ekici B, Tatli B (2017) Neonatal hypoxic ischemic encephalopathy: an update on disease pathogenesis and treatment. Expert Rev Neurother 17(5):449\u2013459","journal-title":"Expert Rev Neurother"},{"key":"4475_CR24","first-page":"7427136","volume":"2023","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Shi M, Li Z, Ling Y, Zhai L, Yuan Y, Ma H, Hao L, Li Z, Zhang Z, Holscher C (2023) A dual GLP-1\/GIP receptor agonist is more effective than liraglutide in the A53T mouse model of parkinson\u2019s disease. Parkinsons Dis 2023:7427136","journal-title":"Parkinsons Dis"},{"issue":"2","key":"4475_CR25","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3233\/JPD-191768","volume":"10","author":"L Zhang","year":"2020","unstructured":"Zhang L, Zhang L, Li Y, Li L, Melchiorsen JU, Rosenkilde M, Holscher C (2020) The novel dual GLP-1\/GIP receptor agonist DA-CH5 is superior to single GLP-1 receptor agonists in the MPTP model of parkinson\u2019s disease. J Parkinsons Dis 10(2):523\u2013542","journal-title":"J Parkinsons Dis"},{"issue":"4","key":"4475_CR26","doi-asserted-by":"publisher","first-page":"9184","DOI":"10.1080\/21655979.2022.2051859","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Cai F, Li G, Tao Y (2022) Novel dual glucagon-like peptide-1\/ glucose-dependent insulinotropic polypeptide receptor agonist attenuates diabetes and myocardial injury through inhibiting hyperglycemia, inflammation and oxidative stress in rodent animals. Bioengineered 13(4):9184\u20139196","journal-title":"Bioengineered"},{"issue":"6","key":"4475_CR27","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/WNR.0000000000000548","volume":"27","author":"L Cao","year":"2016","unstructured":"Cao L, Li D, Feng P, Li L, Xue GF, Li G, Holscher C (2016) A novel dual GLP-1 and GIP incretin receptor agonist is neuroprotective in a mouse model of parkinson\u2019s disease by reducing chronic inflammation in the brain. NeuroReport 27(6):384\u2013391","journal-title":"NeuroReport"},{"issue":"1","key":"4475_CR28","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.numecd.2020.09.002","volume":"31","author":"B Bai","year":"2021","unstructured":"Bai B, Li D, Xue G, Feng P, Wang M, Han Y, Wang Y, Holscher C (2021) The novel GLP-1\/GIP dual agonist DA3-CH is more effective than liraglutide in reducing Endoplasmic reticulum stress in diabetic rats with cerebral ischemia-reperfusion injury. Nutr Metab Cardiovasc Dis 31(1):333\u2013343","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"4475_CR29","doi-asserted-by":"crossref","unstructured":"Teleanu DM, Niculescu AG, Lungu II, Radu CI, Vladacenco O, Roza E, Costachescu B, Grumezescu AM, Teleanu RI (2022) An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases. Int J Mol Sci 23(11)","DOI":"10.3390\/ijms23115938"},{"issue":"4","key":"4475_CR30","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s12031-019-01454-1","volume":"70","author":"D Zhou","year":"2020","unstructured":"Zhou D, Ji L, Chen Y, Modulates TSPO (2020) IL-4-Induced microglia\/macrophage M2 polarization via PPAR-gamma pathway. J Mol Neurosci 70(4):542\u2013549","journal-title":"J Mol Neurosci"},{"issue":"1","key":"4475_CR31","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12031-021-01908-5","volume":"72","author":"X Peng","year":"2022","unstructured":"Peng X, Wang J, Peng J, Jiang H, Le K (2022) Resveratrol improves synaptic plasticity in Hypoxic-Ischemic brain injury in neonatal mice via alleviating SIRT1\/NF-kappaB Signaling-Mediated neuroinflammation. J Mol Neurosci 72(1):113\u2013125","journal-title":"J Mol Neurosci"},{"key":"4475_CR32","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.neuroscience.2017.05.016","volume":"356","author":"JH Koo","year":"2017","unstructured":"Koo JH, Jang YC, Hwang DJ, Um HS, Lee NH, Jung JH, Cho JY (2017) Treadmill exercise produces neuroprotective effects in a murine model of parkinson\u2019s disease by regulating the TLR2\/MyD88\/NF-kappaB signaling pathway. Neuroscience 356:102\u2013113","journal-title":"Neuroscience"},{"issue":"1","key":"4475_CR33","doi-asserted-by":"publisher","first-page":"e29695","DOI":"10.1371\/journal.pone.0029695","volume":"7","author":"J Segovia","year":"2012","unstructured":"Segovia J, Sabbah A, Mgbemena V, Tsai SY, Chang TH, Berton MT, Morris IR, Allen IC, Ting JP, Bose S (2012) TLR2\/MyD88\/NF-kappaB pathway, reactive oxygen species, potassium efflux activates NLRP3\/ASC inflammasome during respiratory syncytial virus infection. PLoS ONE 7(1):e29695","journal-title":"PLoS ONE"},{"key":"4475_CR34","doi-asserted-by":"publisher","first-page":"6654954","DOI":"10.1155\/2021\/6654954","volume":"2021","author":"JJ Zhu","year":"2021","unstructured":"Zhu JJ, Yu BY, Huang XK, He MZ, Chen BW, Chen TT, Fang HY, Chen SQ, Fu XQ, Li PJ, Lin ZL, Zhu JH (2021) Neferine protects against Hypoxic-Ischemic brain damage in neonatal rats by suppressing NLRP3-Mediated inflammasome activation. Oxid Med Cell Longev 2021:6654954","journal-title":"Oxid Med Cell Longev"},{"key":"4475_CR35","doi-asserted-by":"crossref","unstructured":"Wang L, Ding J, Zhu C, Guo B, Yang W, He W, Li X, Wang Y, Li W, Wang F, Sun T (2021) Semaglutide attenuates seizure severity and ameliorates cognitive dysfunction by blocking the NLR family Pyrin domain containing 3 inflammasome in pentylenetetrazole\u2013kindled mice. Int J Mol Med 48(6)","DOI":"10.3892\/ijmm.2021.5052"},{"issue":"3","key":"4475_CR36","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/cns.13791","volume":"28","author":"S Song","year":"2022","unstructured":"Song S, Guo R, Mehmood A, Zhang L, Yin B, Yuan C, Zhang H, Guo L, Li B (2022) Liraglutide attenuate central nervous inflammation and demyelination through AMPK and pyroptosis-related NLRP3 pathway. CNS Neurosci Ther 28(3):422\u2013434","journal-title":"CNS Neurosci Ther"},{"key":"4475_CR37","doi-asserted-by":"publisher","first-page":"109806","DOI":"10.1016\/j.diabres.2022.109806","volume":"186","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Li Q, Liu S, Zheng H, Ji L, Yi N, Bao W, Zhu X, Sun W, Liu X, Zhang S, Zuo C, Li Y, Xiong Q, Lu B (2022) Glucagon-like peptide-1 receptor agonist attenuates diabetic neuropathic pain via Inhibition of NOD-like receptor protein 3 inflammasome in brain microglia. Diabetes Res Clin Pract 186:109806","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"4475_CR38","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1186\/s12967-023-04452-5","volume":"21","author":"Y Chen","year":"2023","unstructured":"Chen Y, Li X, Xiong Q, Du Y, Luo M, Yi L, Pang Y, Shi X, Wang YT, Dong Z (2023) Inhibiting NLRP3 inflammasome signaling pathway promotes neurological recovery following hypoxic-ischemic brain damage by increasing p97-mediated surface GluA1-containing AMPA receptors. J Transl Med 21(1):567","journal-title":"J Transl Med"},{"key":"4475_CR39","doi-asserted-by":"publisher","first-page":"812362","DOI":"10.3389\/fphar.2022.812362","volume":"13","author":"Y Chai","year":"2022","unstructured":"Chai Y, Cai Y, Fu Y, Wang Y, Zhang Y, Zhang X, Zhu L, Miao M, Yan T (2022) Salidroside Ameliorates Depression by Suppressing NLRP3-Mediated Pyroptosis via P2X7\/NF-kappaB\/NLRP3 Signaling Pathway. Front Pharmacol 13:812362","journal-title":"Front Pharmacol"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-025-04475-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-025-04475-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-025-04475-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T13:07:54Z","timestamp":1757250474000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-025-04475-y"}},"subtitle":["The role of DA5-CH in neonatal hypoxic-ischemic encephalopathy"],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["4475"],"URL":"https:\/\/doi.org\/10.1007\/s11064-025-04475-y","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,17]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were conducted in accordance with the Guide for the Institutional Animal Care and Use and approved by the Institutional Animal Care and Use Committee of The Affiliated Children\u2019s Hospital of Xiangya School of Medicine, Central South University (Hunan children\u2019s hospital).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient Consent"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"235"}}